Tokyo Tape
Sign in
← Sapporo Clinical Laboratory

Quarterly report · Q1

9776.TEDINET S100OYM4
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥4.9bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥19.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥4.6bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥132m2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥292m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥223m2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥1.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥294m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥222m2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥191m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥78m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥107m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥125m2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥106m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥16.2bnat 2022-06-30Cons.Assets
Total assets¥16.1bnat 2022-03-31Cons.Assets
Total assets¥14.7bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.8bnat 2022-06-30Cons.Liabilities
Total liabilities¥5.8bnat 2022-03-31Cons.Liabilities
Net assets / equity¥10.4bnat 2022-06-30Cons.Net assets
Net assets / equity¥10.3bnat 2022-03-31Cons.Net assets
Net assets / equity¥9.5bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥3.6bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥3.0bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥23.352022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥306.162021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥31.312021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio62.3%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio62.6%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio63.0%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 44
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥22m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥846,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥15m
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.1bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥200m
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.5bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥78m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥376m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥233m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥143m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentsegment profit2022-04-01 → 2022-06-30−¥3m
—segment totalrevenue2022-04-01 → 2022-06-30¥5.0bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥143m
—segment totalsegment profit2022-04-01 → 2022-06-30¥275m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥144m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥290m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥351,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥11m
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E04950-000Clinical Testing Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥304m
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥2.6bn
jpcrp040300-q1r_E04950-000Dispensing Pharmacy Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥131m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue2021-04-01 → 2021-06-30¥710m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue external2021-04-01 → 2021-06-30¥170m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥539m
jpcrp040300-q1r_E04950-000Medical Devices Sales And Maintenance Businessreportable segmentsegment profit2021-04-01 → 2021-06-30¥7m
—segment totalrevenue2021-04-01 → 2021-06-30¥5.2bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥4.6bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥539m
—segment totalsegment profit2021-04-01 → 2021-06-30¥442m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥5.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥540m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥453m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 380
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant885400
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant885400
Shareholding ratio treasury shares etcCurrentQuarterInstant0.2100
Cash and depositsPrior1YearInstant2990653000JPY
Cash and depositsCurrentQuarterInstant3633721000JPY
Notes and accounts receivable trade and contract assetsPrior1YearInstant3023730000JPY
Notes and accounts receivable trade and contract assetsCurrentQuarterInstant2913999000JPY
Merchandise and finished goodsPrior1YearInstant409540000JPY
Merchandise and finished goodsCurrentQuarterInstant546842000JPY
Work in processPrior1YearInstant26799000JPY
Work in processCurrentQuarterInstant30137000JPY
Raw materials and suppliesPrior1YearInstant54352000JPY
Raw materials and suppliesCurrentQuarterInstant50542000JPY
Other caPrior1YearInstant753319000JPY
Other caCurrentQuarterInstant125952000JPY
Allowance for doubtful accounts caPrior1YearInstant-28751000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-27083000JPY
Current assetsPrior1YearInstant7229644000JPY
Current assetsCurrentQuarterInstant7274112000JPY
Buildings and structuresPrior1YearInstant4960833000JPY
Buildings and structuresCurrentQuarterInstant5022471000JPY
Accumulated depreciation buildings and structuresPrior1YearInstant-1297726000JPY
Accumulated depreciation buildings and structuresCurrentQuarterInstant-1352562000JPY
Buildings and structures netPrior1YearInstant3663106000JPY
Buildings and structures netCurrentQuarterInstant3669908000JPY
Machinery equipment and vehiclesPrior1YearInstant27089000JPY
Machinery equipment and vehiclesCurrentQuarterInstant25892000JPY
Accumulated depreciation machinery equipment and vehiclesPrior1YearInstant-22030000JPY
Accumulated depreciation machinery equipment and vehiclesCurrentQuarterInstant-21400000JPY
Machinery equipment and vehicles netPrior1YearInstant5059000JPY
Machinery equipment and vehicles netCurrentQuarterInstant4491000JPY
Tools furniture and fixturesPrior1YearInstant2148429000JPY
Tools furniture and fixturesCurrentQuarterInstant2173783000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant-1766731000JPY
Accumulated depreciation tools furniture and fixturesCurrentQuarterInstant-1796000000JPY
Tools furniture and fixtures netPrior1YearInstant381697000JPY
Tools furniture and fixtures netCurrentQuarterInstant377782000JPY
LandPrior1YearInstant3429506000JPY
LandCurrentQuarterInstant3429506000JPY
Lease assets ppePrior1YearInstant715290000JPY
Lease assets ppeCurrentQuarterInstant719283000JPY
Accumulated depreciation lease assets ppePrior1YearInstant-66959000JPY
Accumulated depreciation lease assets ppeCurrentQuarterInstant-86369000JPY
Lease assets net ppePrior1YearInstant648331000JPY
Lease assets net ppeCurrentQuarterInstant632914000JPY
Property plant and equipmentPrior1YearInstant8127702000JPY
Property plant and equipmentCurrentQuarterInstant8114604000JPY
Other iaPrior1YearInstant60128000JPY
Other iaCurrentQuarterInstant59447000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass